Original Article

Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States

Michael S. Broder, MD, MSHS; Qiufei Ma, PhD; Tingjian Yan, PhD; Jie Zhang, PhD; Eunice Chang, PhD; David Kuzan, MD; Lamis Eldjerou, MD

Business, Original Article

Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption

Cori Gray, PharmD; James T. Kenney, RPh, MBA

Stakeholder Perspective

Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods

Gary Branning, MBA

Clinical, Original Article

Employer-Sponsored Wellness Programs for Hypertension and Dyslipidemia in a 2-Hospital Health System

Anne Misher, PharmD, BCACP, BC-ADM, CDE; Jessica Brown, PharmD; Christina Maguire, PharmD; Alix P. Schnibben, PharmD, BCACP, CTTS

Stakeholder Perspective

Benefits of Employer-Sponsored Wellness Programs for Chronic Diseases

F. Randy Vogenberg, RPh, PhD, FASHP

Results 1 - 3 of 3

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.